Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
National Institutes of Health
Award
USD 0–750K ≈ €0–€690K
Closing date
568 days left · Oct 20, 2027
Location
Global
For
Orgs
About this opportunity
This funding opportunity announcement (FOA) encourages research grant applications to develop in vitro and/or ex vivo assays and conduct iterative screening efforts to identify and characterize potential therapeutic agents for neurological or neuromuscular disorders. This FOA is part of a suite of Innovation Grants to Nurture Initial Translational Efforts (IGNITE) to advance projects to the point where they can meet the entry criteria for the Blueprint Neurotherapeutics Network (BPN) or other translational programs. The program aims to support early-stage translational research that bridges the gap between basic science discoveries and clinical applications in neuroscience. Projects funded under this mechanism will focus on assay development and the identification of neurotherapeutic agents for disorders affecting the nervous system and neuromuscular function.
Who can apply
Applicant Types
organization
Organization Types
nonprofit, for profit, academic, government, tribal
Project Locations
🇺🇸 United States
Region
United States
How to apply
Stages
- 1 single_stage
Required documents
research_proposal · budget
Restrictions
- reporting_requirements
Post-award obligations
- final_report
- acknowledge_funder
External listing — not managed by a verified Grantory funder
External Application
This opportunity requires you to apply directly on the funder's website.
Apply on External SiteAI-Extracted Data
This opportunity was automatically extracted from an external source using AI. Details such as amounts, closing dates, and eligibility may be incomplete or inaccurate.
Always verify on the official source